Compositions and methods for treating phenylketonuria
US-2024141381-A1 · May 2, 2024 · US
Vibrio parahaemolyticus bacteriophage Vib-PAP-2 and use thereof for inhibiting proliferation of Vibrio parahaemolyticus
US11020442B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11020442-B2 |
| Application number | US-201616064725-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 10, 2016 |
| Priority date | Dec 21, 2015 |
| Publication date | Jun 1, 2021 |
| Grant date | Jun 1, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to: Podoviridae bacteriophage Vib-PAP-2 (accession number KCTC 12910BP) which has the capability to specifically destroy Vibrio parahaemolyticus, is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treating Vibrio parahaemolyticus infections, using a composition containing bacteriophage Vib-PAP-2 as an active ingredient.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating or decreasing the probability for developing an infection of Vibrio parahaemolyticus , which comprises a step of administering to a subject a composition comprising the Podoviridae bacteriophage Vib-PAP-2 (Accession NO: KCTC 12910BP) that can kill Vibrio parahaemolyticus cells specifically, wherein the Podoviridae bacteriophage Vib-PAP-2 comprises a genome represented by the nucleotide sequence of SEQ. ID. NO: 1, as an active ingredient. 2. The method for treating or decreasing the probability for developing an infection of Vibrio parahaemolyticus according to claim 1 , wherein said composition is administered to a subject in the form of an immersion agent or a feed additive.
Assignees
Inventors
Classifications
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent · CPC title
Washing or bathing preparations · CPC title
- A61K35/76Primary
Viruses; Subviral particles; Bacteriophages · CPC title
Viruses as such, e.g. new isolates, mutants or their genomic sequences · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11020442B2 cover?
- The present invention relates to: Podoviridae bacteriophage Vib-PAP-2 (accession number KCTC 12910BP) which has the capability to specifically destroy Vibrio parahaemolyticus, is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treating Vibrio parahaemolyticus infections, using a composition containing bacteriophage Vib-P…
- Who is the assignee on this patent?
- Intron Biotechnology Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K35/76. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).